[Effectiveness of 2 drug forms of nitroglycerin--transdermal (preparation Nitroderm-TTS) and gingival application (preparation Trinitrolong)--in ischemic heart disease patients].
D000287:Administration, Topical; D000787:Angina Pectoris / Q000188:drug therapy / Q000503:physiopathology; D002908:Chronic Disease; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D004562:Electrocardiography; D005881:Gingiva; D006334:Heart Function Tests; D006801:Humans; D008875:Middle Aged; D005996:Nitroglycerin / Q000008:administration & dosage*; D013997:Time Factors
D003692:Delayed-Action Preparations; D005996:Nitroglycerin
Izuchenie éffektivnosti dvukh lekarstvennykh form nitroglitserina--transdermal'noĭ (preparat nitroderm-TTS) i applikatsii na desnu (preparat trinitrolong) u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.